Cdc37 suppression induces plasma cell immaturation and bortezomib resistance in multiple myeloma via Xbp1s
Detection of a rare BCR-ABL tyrosine kinase fusion protein in H929 multiple myeloma cells using immunoprecipitation (IP)-tandem mass spectrometry (MS/MS). - Abstract - Europe PMC
A novel xenograft mouse model for testing approaches targeting human kappa light-chain diseases | Gene Therapy
Detection of a rare BCR–ABL tyrosine kinase fusion protein in H929 multiple myeloma cells using immunoprecipitation (IP)-tandem mass spectrometry (MS/MS) | PNAS
Response of myeloma to the proteasome inhibitor bortezomib is correlated with the unfolded protein response regulator XBP-1 | Haematologica
WO2015081613A1 - ANTI-HUMAN mIgA ANTIBODIES CAPABLE OF LYSING mIgA-B LYMPHOCYTES AND DECREASING IgA PRODUCTION - Google Patents
Establishment and Characterization of a Human Plasma Cell Myeloma Culture Having a Rearranged Cellular myc Proto-oncogene - ScienceDirect
Detection of a rare BCR–ABL tyrosine kinase fusion protein in H929 multiple myeloma cells using immunoprecipitation (IP)-tandem mass spectrometry (MS/MS) | PNAS
miR-221/222-Mediated Inhibition of Autophagy Promotes Dexamethasone Resistance in Multiple Myeloma
The Expression and Localization of Kappa Myeloma Antigen on Malignant and Normal B cells
Cancers | Free Full-Text | The FMS like Tyrosine Kinase 3 (FLT3) Is Overexpressed in a Subgroup of Multiple Myeloma Patients with Inferior Prognosis | HTML
Types of Multiple Myeloma | International Myeloma Foundation
Establishment of Five Human Myeloma Cell Lines
plus dead) labeled
Heterogeneity and Plasticity of Multiple Myeloma | IntechOpen
PDF) Illegitimate WNT signaling promotes proliferation of multiple myeloma cells
NCI-H929细胞ATCC CRL-9068细胞H929人骨髓瘤细胞株购买价格、培养基、培养条件、细胞图片、特征等基本信息_生物风
Intense Uptake of Liposomal Curcumin by Multiple Myeloma Cell Lines: Comparison to Normal Lymphocytes, Red Blood Cells and Chron
Myeloma-derived IL-32γ induced PD-L1 expression in macrophages facilitates immune escape via the PFKFB3-JAK1 axis
Cell adhesion molecule CD166 drives malignant progression and osteolytic disease in multiple myeloma
Cell adhesion molecule CD166 drives malignant progression and osteolytic disease in multiple myeloma
Upregulated expression and function of the α4β1 integrin in multiple myeloma cells resistant to bortezomib - Sevilla‐Movilla - 2020 - The Journal of Pathology - Wiley Online Library
-Immunocytochemistry-Immunofluorescence-NBP2-34258-img0004.jpg "Kappa Light Chain Antibody (HP6053 + L1C1) (NBP2-34258): Novus Biologicals")
Kappa Light Chain Antibody (HP6053 + L1C1) (NBP2-34258): Novus Biologicals
Establishment of a bortezomib-resistant Chinese human multiple myeloma cell line: MMLAL
